SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is facing intense market volatility and significant analyst downgrades following a weak bookings guidance reset and the disruptive impact of its new age verification rollout. The community remains deeply polarized, with many investors debating whether the current selloff offers a buying opportunity in a sticky platform or if persistent safety concerns and slowing growth justify further downside.

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology). The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.

Cue Biopharma Inc

Cue Biopharma is trending following the announcement of a $30 million private placement and a new licensing deal for an anti-IgE asset, which has triggered intense speculation regarding its potential for a short squeeze among retail traders. While some investors are highlighting the company's clinical pipeline and low float as catalysts for a major rally, others remain skeptical, pointing to the effective offering price and potential dilution risks.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is trending as investors digest a massive earnings beat, with the community actively debating whether the company's strong monetization and user growth can spark a sustained rally or if the stock will face typical post-earnings volatility. While bulls point to improved profitability and long-term data licensing potential as catalysts for a squeeze, bears remain skeptical, citing concerns over user engagement quality and historical patterns of post-report pullbacks.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is experiencing significant bullish momentum driven by the upcoming presentation of its pancreatic cancer trial data at Digestive Disease Week, which has investors anticipating a major clinical breakthrough. Community sentiment remains overwhelmingly optimistic, with retail traders aggressively accumulating shares and discussing potential catalystsincluding trial expansions and upcoming gala eventsas the stock continues to trend on high volume.

Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The company cultivates and processes natural cannabis at facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers. It also imports and sells medical cannabis-based products. The company was founded on July 16, 2021 and is headquartered in New Romney, the United Kingdom.

Akanda Corp

Akanda Corp is experiencing extreme volatility and a parabolic rally driven by a extremely low tradeable float, which has triggered an aggressive short squeeze as borrow fees have surged toward 1000%. The community is intensely debating the sustainability of this run, with many bullish traders focused on momentum and the potential for forced short covering, while skeptics point to the company's history of reverse splits and warn of an inevitable correction.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is seeing significant market activity following a record-breaking fiscal quarter that featured double-digit revenue growth and a new $100 billion share buyback authorization. Investors are actively debating the leadership transition to incoming CEO John Ternus and the company's long-term growth outlook, with community discussion centered on supply chain constraints, margin pressure from memory costs, and anticipation for upcoming AI product reveals.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is experiencing extreme volatility following a massive quarterly earnings beat that saw revenue triple and guidance raised, with the community divided between bulls viewing the pullback as a gift and bears warning of a potential bubble after a year of historic gains. Investors are closely monitoring the $6 billion share buyback announcement and the company's aggressive expansion into AI data center infrastructure as key indicators for whether the stock can maintain its upward trajectory.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics Holdings is facing intense downward pressure and community criticism following the announcement of an $80 million capital raise through a common stock and pre-funded warrant offering. Investors are actively debating the company's management execution and the potential for further dilution, as the stock struggles to find footing amidst recurring concerns over the firm's long-term business model.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is surging following a major $950 million patent settlement that removes significant litigation overhang and allows investors to refocus on its promising oncology and respiratory pipeline. Community sentiment is highly energized as institutional accumulation grows, with many traders anticipating that the resolution of these legal hurdles paves the way for further upside momentum.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is attracting significant investor attention following a powerful earnings report where it beat revenue expectations and raised guidance, highlighting the success of its AI-driven Athena platform. The community is actively debating the stock's potential for a short squeeze and its long-term growth prospects, with many bulls emphasizing its consistent beat-and-raise history as evidence of strong operational execution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Newly listed options deliver another trading tool to express high conviction views on growth stocks including Astera Labs and MongoDBNEW YORK, Aug. 26, 2025 /PRNewswire/ -- <a target="_blank" rel="noopener noreferrer nofollow" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4494959-1&amp;h=2649503750&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=Tradr+ETFs">Tradr ETFs</a>,&nbsp;a provider of ETFs designed for sophisticated investors and professional traders, today announced that options trading is now available on its four newest leveraged ETFs: the Tradr 2X Long ALAB Daily ETF (Cboe: LABX), the Tradr 2X Long DDOG Daily ETF (Cboe: DOGD), the Tradr 2X Long MDB Daily ETF (Cboe: MDBX), and the Tradr 2X Long LRCX Daily ETF (Cboe: LRCU).The four ETFs, all first-to-market products launched in August, allow traders to express their high conviction views on underlying stocks with strong ties to the AI data center boom: Astera Labs (Nasdaq: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/options-trading-available-on-recently-launched-tradr-etfs-labx-dogd-mdbx-and-lrcu-302538420.html#financial-modal">ALAB</a>), Datadog (Nasdaq: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/options-trading-available-on-recently-launched-tradr-etfs-labx-dogd-mdbx-and-lrcu-302538420.html#financial-modal">DDOG</a>), MongoDB (Nasdaq: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/options-trading-available-on-recently-launched-tradr-etfs-labx-dogd-mdbx-and-lrcu-302538420.html#financial-modal">MDB</a>) and Lam Research (Nasdaq: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/options-trading-available-on-recently-launched-tradr-etfs-labx-dogd-mdbx-and-lrcu-302538420.html#financial-modal">LRCX</a>)."The launch of options trading on the four newest Tradr ETFs gives investors yet another tool to help navigate one of the most transformative investment themes of our time," said Matt Markiewicz, Head of Product and Capital Markets at Tradr ETFs.For detailed information on Tradr ETFs and the significant risks involved with leveraged ETFs, please visit <a target="_blank" rel="noopener noreferrer nofollow" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4494959-1&amp;h=791121047&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=www.tradretfs.com">www.tradretfs.com</a>.About Tradr ETFs <a target="_blank" rel="noopener noreferrer nofollow" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4494959-1&amp;h=2649503750&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=Tradr+ETFs">Tradr ETFs</a>&nbsp;are designed for sophisticated investors and professional traders&nbsp;who are looking to express high conviction investment views. The strategies include leveraged and inverse ETFs that seek short or long exposure to actively traded stocks and ETFs.IMPORTANT RISK INFORMATIONTradr ETFs are for sophisticated investors and professional traders with high conviction views and are very different from most other ETFs. The Funds are intended to be used as short-term trading vehicles and pursue leveraged investment objectives, which means they are riskier than alternatives that do not use leverage because the Funds magnify the performance of their underlying security. The volatility of the underlying security may affect a Fund's return as much as, or more than, the return of the underlying security.Investors in the fund should: (a) understand the risks associated with the use of leverage; (b) understand the consequences of seeking inverse and leveraged investment results; (c) for short ETFs, understand the risk of shorting; (d) intend to actively monitor and manage their investment. Fund performance will likely be significantly different than the benchmark over periods longer than the specified reset period and the performance may trend in the opposite direction than its benchmark over periods other than that period.Leverage increases the risk of a total loss of an investor's investment, may increase the volatility of the Funds, and may magnify any differences between the performance of the Funds and their reference security. The Funds seek leveraged investment results for a specific period (daily, monthly or quarterly). The exact exposure of an investment in the Fund intra-period will depend upon the movement of the reference security from the end of the prior period until the time of investment by the investor.The Fund will not attempt to position its portfolio to ensure it does not gain or lose more than a maximum percentage of its net asset value on a given trading day. As a consequence, investors in a Fund that seeks two times daily performance would lose all of their money if the Fund's underlying security moves more than 50% in a direction adverse to the Fund on a given trading day. Principal risks and other important risks may be found in the prospectus. Past performance does not guarantee future results.ETFs involve risk including possible loss of the full principal value. There is no assurance that the Fund will achieve its investment objective.ETF shares are bought and sold at market price (not NAV) and are not individually redeemed from the ETF. There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur brokerage costs that detract significantly from investment returns.Investors should carefully consider the investment objectives, risks, charges and expenses of the Funds. This and other important information about the Fund is contained in the Prospectus, which can be obtained by visiting <a target="_blank" rel="noopener noreferrer nofollow" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4494959-1&amp;h=791121047&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=www.tradretfs.com">www.tradretfs.com</a>. The Prospectus should be read carefully before investing.Distributed by ALPS Distributors, Inc, which is not affiliated with AXS Investments or its Tradr ETFs. AXI000737SOURCE Tradr ETFs

Options Trading Available on Recently Launched Tradr ETFs: LABX, DOGD, MDBX and LRCU

Newly listed options deliver another trading tool to express high conviction views on growth stocks including Astera Labs and MongoDB

Options Trading Available on Recently Launched Tradr ETFs

Others

Two new 2X long single-stock ETFs focused on high-growth tech companiesNEW YORK, Aug. 19, 2025 /PRNewswire/ -- <a target="_blank" rel="noopener noreferrer nofollow" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4490574-1&amp;h=961928574&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=Tradr+ETFs">Tradr ETFs</a>,&nbsp;a provider of ETFs designed for sophisticated investors and professional traders, today announced the launch of two new single-stock leveraged ETFs on Lam Research &amp; MongoDB. Both funds are first-to-market strategies and are listed on Cboe. The funds aim to deliver twice (200%) the daily performance of their underlying stock.The two newly launched ETFs are:<ul style="list-style-type:disc;"><li><a target="_blank" rel="noopener noreferrer nofollow" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4490574-1&amp;h=4111046924&amp;u=http%3A%2F%2Fwww.tradretfs.com%2Flrcu&amp;a=Tradr+2X+Long+LRCX+Daily+ETF+(Cboe%3A+LRCU)">Tradr 2X Long LRCX Daily ETF (Cboe: LRCU)</a> – tracks Lam Research Corp. (Nasdaq: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tradr-unveils-first-to-market-leveraged-etfs-on-lam-research--mongodb-302532656.html#financial-modal">LRCX</a>) &nbsp;</li><li><a target="_blank" rel="noopener noreferrer nofollow" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4490574-1&amp;h=1815139624&amp;u=http%3A%2F%2Fwww.tradretfs.com%2Fmdbx&amp;a=Tradr+2X+Long+MDB+Daily+ETF+(Cboe%3A+MDBX)">Tradr 2X Long MDB Daily ETF (Cboe: MDBX)</a> – tracks MongoDB Inc. (Nasdaq: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tradr-unveils-first-to-market-leveraged-etfs-on-lam-research--mongodb-302532656.html#financial-modal">MDB</a>)</li></ul>"Traders' relentless thirst for stocks engaged in the AI-stack remains unabated, and we are excited to bring two more relevant leveraged strategies to market," said Matt Markiewicz, Head of Product and Capital Markets at Tradr ETFs. "While Lam has a been a stalwart semi-manufacturing stock for decades, it is now garnering new investor interest from its involvement in supporting AI-driven semi demand. Meanwhile, although it has been public for nearly eight years, MongoDB's database-as-a-service has begun to carve out a valuable niche in the Gen-AI theme."These latest two launches follow the recent debut of several first-to-market leveraged single-stock ETFs including: LABX, DOGD, CWVX, SMU and ASTX, respectively covering Astera Labs Inc. (Nasdaq: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tradr-unveils-first-to-market-leveraged-etfs-on-lam-research--mongodb-302532656.html#financial-modal">ALAB</a>), Datadog Inc. (Nasdaq: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tradr-unveils-first-to-market-leveraged-etfs-on-lam-research--mongodb-302532656.html#financial-modal">DDOG</a>), CoreWeave Inc. (Nasdaq: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tradr-unveils-first-to-market-leveraged-etfs-on-lam-research--mongodb-302532656.html#financial-modal">CRWV</a>), NuScale Power Corp. (NYSE: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tradr-unveils-first-to-market-leveraged-etfs-on-lam-research--mongodb-302532656.html#financial-modal">SMR</a>), and AST SpaceMobile Inc. (Nasdaq: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tradr-unveils-first-to-market-leveraged-etfs-on-lam-research--mongodb-302532656.html#financial-modal">ASTS</a>). In 2022, Tradr ETFs became the first issuer to launch leveraged ETFs on single stocks, starting with TSLQ for Tesla and NVDS for Nvidia.Tradr's leveraged ETFs can be traded through most brokerage platforms and allow investors to avoid the hassle of using margin and the complexity of options trading. With this launch, Tradr's lineup grows to 23 leveraged ETFs. The firm continues its mission of providing sophisticated investors with innovative trading tools that enhance their ability to express market views with precision and efficiency.For detailed information on Tradr ETFs and the significant risks involved with leveraged ETFs, please visit <a target="_blank" rel="noopener noreferrer nofollow" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4490574-1&amp;h=2342414831&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=www.tradretfs.com">www.tradretfs.com</a>.About Tradr ETFs <a target="_blank" rel="noopener noreferrer nofollow" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4490574-1&amp;h=961928574&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=Tradr+ETFs">Tradr ETFs</a>&nbsp;are designed for sophisticated investors and professional traders&nbsp;who are looking to express high conviction investment views. The strategies include leveraged and inverse ETFs that seek short or long exposure to actively traded stocks and ETFs.IMPORTANT RISK INFORMATIONTradr ETFs are for sophisticated investors and professional traders with high conviction views and are very different from most other ETFs. The Funds are intended to be used as short-term trading vehicles and pursue leveraged investment objectives, which means they are riskier than alternatives that do not use leverage because the Funds magnify the performance of their underlying security. The volatility of the underlying security may affect a Fund's return as much as, or more than, the return of the underlying security.Investors in the fund should: (a) understand the risks associated with the use of leverage; (b) understand the consequences of seeking inverse and leveraged investment results; (c) for short ETFs, understand the risk of shorting; (d) intend to actively monitor and manage their investment. Fund performance will likely be significantly different than the benchmark over periods longer than the specified reset period and the performance may trend in the opposite direction than its benchmark over periods other than that period.Leverage increases the risk of a total loss of an investor's investment, may increase the volatility of the Funds, and may magnify any differences between the performance of the Funds and their reference security. The Funds seek leveraged investment results for a specific period (daily, monthly or quarterly). The exact exposure of an investment in the Fund intra-period will depend upon the movement of the reference security from the end of the prior period until the time of investment by the investor.The Fund will not attempt to position its portfolio to ensure it does not gain or lose more than a maximum percentage of its net asset value on a given trading day. As a consequence, investors in a Fund that seeks two times daily performance would lose all of their money if the Fund's underlying security moves more than 50% in a direction adverse to the Fund on a given trading day.ETFs involve risk including possible loss of the full principal value. There is no assurance that the Fund will achieve its investment objective. Principal risks and other important risks may be found in the prospectus. Past performance does not guarantee future results.ETF shares are bought and sold at market price (not NAV) and are not individually redeemed from the ETF. There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur brokerage costs that detract significantly from investment returns.Investors should carefully consider the investment objectives, risks, charges and expenses of the Funds. This and other important information about the Fund is contained in the Prospectus, which can be obtained by visiting <a target="_blank" rel="noopener noreferrer nofollow" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4490574-1&amp;h=2342414831&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=www.tradretfs.com">www.tradretfs.com</a>. The Prospectus should be read carefully before investing.Distributed by ALPS Distributors, Inc, which is not affiliated with AXS Investments or its Tradr ETFs. AXI000733SOURCE Tradr ETFsNote: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.

Tradr Unveils First-to-Market Leveraged ETFs on Lam Research & MongoDB

https://www.prnewswire.com/news-releases/tradr-unveils-first-to-market-leveraged-etfs-on-lam-research--mongodb-302532656.html

Current Price	$0.0482
Prev Close	$0.0478
Open	$0.0478
Dividend Yield	N/A
50-Day Moving Average	$28.61
Beta	N/A
Avg. Volume	106,294.40
PE Ratio	N/A

52-Week High	$78.80
52-Week Low	$15.11
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

MDBX
Tradr 2X Long MDB Daily ETF

Feed

News

Sentiment

Fundamentals

Info

Latest MDBX News

MDBXTradr 2X Long MDB Daily ETF